Principal Financial Group’s Vaxart VXRT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-39,019
Closed -$29.5K 2496
2023
Q1
$29.5K Buy
39,019
+1,453
+4% +$1.35K ﹤0.01% 2405
2022
Q4
$36.1K Buy
37,566
+9,053
+32% +$12.8K ﹤0.01% 2380
2022
Q3
$62K Buy
28,513
+5,448
+24% +$18.8K ﹤0.01% 2394
2022
Q2
$80K Sell
23,065
-12,080
-34% -$45.1K ﹤0.01% 2418
2022
Q1
$177K Buy
35,145
+664
+2% +$3.36K ﹤0.01% 2358
2021
Q4
$216K Sell
34,481
-12,600
-27% -$86K ﹤0.01% 2339
2021
Q3
$374K Buy
47,081
+1,282
+3% +$10.6K ﹤0.01% 2251
2021
Q2
$343K Sell
45,799
-751,265
-94% -$5.25M ﹤0.01% 2316
2021
Q1
$4.82M Buy
797,064
+75,471
+10% +$581K ﹤0.01% 1677
2020
Q4
$4.12M Buy
+721,593
New +$4.59M ﹤0.01% 1635

Other funds holding VXRT

Principal Financial Group's VXRT Position: Q2 2023 in Review

Principal Financial Group sold out of Vaxart (VXRT) in Q2 2023, closing a stake of 39,019 shares — an estimated $29.5K sold.

Principal Financial Group first reported a position in VXRT in Q4 2020 and held it in 10 quarters. The position peaked at $4.82M in Q1 2021. 111 funds tracked by Wall St. Rank hold VXRT as of Q2 2023.

  • Principal Financial Group reported no remaining Vaxart position as of Q2 2023 after selling out during the quarter.
  • Principal Financial Group sold 39,019 Vaxart shares in Q2 2023, an estimated $29.5K.
  • Principal Financial Group first reported a position in Vaxart in Q4 2020 and held it in 10 quarters.
  • Principal Financial Group's Vaxart position peaked at $4.82M in Q1 2021.
  • 111 funds tracked by Wall St. Rank held Vaxart as of Q2 2023.

Based on Principal Financial Group's 13F filing for Q2 2023, filed 7 Aug 2023.